Inventor · disambiguated record
Theresa A. Shapiro
Also filed as: SHAPIRO THERESA · SHAPIRO THERESA A
7 granted patents·3 pending applications·128 citations·filing 1994–2023
87Inventor score
Top patents by PatentIndex Score
10 records- 0182US6586464B2Artemisinin analogs having antimalarial, antiproliferative, and antitumor activities and chemoselective methods of making the sameUNIV JOHNS HOPKINS·Filed 2001·Granted Jul 1, 2003·12 cites·16 claims
- 0278US6156790AC-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activitiesHAUSER INC·Filed 1997·Granted Dec 5, 2000·22 cites·30 claims
- 0372US7417156B2Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimersUNIV JOHNS HOPKINS·Filed 2003·Granted Aug 26, 2008·7 cites·85 claims
- 0472US5496830AInhibition of hemoflagellates by camptothecin compoundsUNIV JOHNS HOPKINS·Filed 1994·Granted Mar 5, 1996·44 cites·19 claims
- 0570US2023218547A1Chemical compositionUNIV LIVERPOOL·Filed 2023·Application pending·0 cites
- 0669US6297272B1Artemisinin analogs having antimalarial antiproliferative and antitumor activities and chemoselective methods of making the sameHAUSER INC·Filed 1999·Granted Oct 2, 2001·12 cites·27 claims
- 0762US6160004AC-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activitiesHAUSER INC·Filed 1998·Granted Dec 12, 2000·25 cites·19 claims
- 0857US6136847AWater-soluble trioxanes as potent and safe antimalarial agentsUNIV JOHNS HOPKINS·Filed 1999·Granted Oct 24, 2000·6 cites·15 claims
- 0946US2019321310A1Chemical compositionUNIV LIVERPOOL·Filed 2017·Application pending·0 cites
- 1042US2020155481A1Intramuscular atovaquone for malaria prophylaxisUNIV JOHNS HOPKINS·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Theresa A. Shapiro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →